| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $9,505,619 | 15 | 100 |
| Cohen Cheryl | director | 0 | $0 | 2 | $2.1M | $-2.1M |
| Selecky Christobel | director | 0 | $0 | 6 | $3M | $-3M |
| Simon Barry J. | director | 0 | $0 | 7 | $4.41M | $-4.41M |
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion proteins, synthetically engineered immunomodulators, cutting-edge vaccine technologies, natural killer (NK) cell therapies, and …
Over the last 12 months, insiders at ImmunityBio, Inc. have bought $0 and sold $9.51M worth of ImmunityBio, Inc. stock.
On average, over the past 5 years, insiders at ImmunityBio, Inc. have bought $330,793 and sold $9.51M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 71,915 shares for transaction amount of $198,023 was made by BLASZYK MICHAEL D (director) on 2023‑06‑05.
| 2026-10-05 | Sale | Simon Barry J. | director | 25,000 0.0025% | $10.75 | $268,760 | -15.51% | |
| 2026-10-02 | Sale | Cohen Cheryl | director | 81,056 0.0079% | $10.50 | $851,088 | -14.54% | |
| 2026-07-02 | Sale | Cohen Cheryl | director | 131,210 0.0126% | $9.50 | $1.25M | -13.51% | |
| 2026-07-01 | Sale | Selecky Christobel | director | 159,478 0.0149% | $9.02 | $1.44M | -10.98% | |
| 2026-06-30 | Sale | Selecky Christobel | director | 1,000 <0.0001% | $9.00 | $9,000 | -6.51% | |
| 2026-06-29 | Sale | Selecky Christobel | director | 95,722 0.0094% | $9.01 | $862,216 | -6.61% | |
| 2026-06-24 | Sale | Simon Barry J. | director | 25,000 0.0026% | $7.88 | $196,908 | +5.19% | |
| 2026-06-04 | Sale | Simon Barry J. | director | 23,033 0.0022% | $7.18 | $165,306 | +10.56% | |
| 2026-02-24 | Sale | Simon Barry J. | director | 75,000 0.0079% | $12.01 | $900,788 | -31.17% | |
| 2026-02-23 | Sale | Simon Barry J. | director | 165,000 0.0175% | $10.25 | $1.69M | -19.13% | |
| 2026-02-23 | Sale | Selecky Christobel | director | 25,000 0.0026% | $10.00 | $250,000 | -19.13% | |
| 2026-02-20 | Sale | Simon Barry J. | director | 10,000 0.0011% | $9.25 | $92,500 | -8.62% | |
| 2026-01-20 | Sale | Simon Barry J. | director | 151,967 0.0171% | $7.20 | $1.09M | +21.60% | |
| 2026-01-20 | Sale | Selecky Christobel | director | 25,000 0.0029% | $7.51 | $187,650 | +21.60% | |
| 2026-01-16 | Sale | Selecky Christobel | director | 50,000 0.0046% | $5.00 | $250,000 | +42.66% | |
| 2023-06-05 | BLASZYK MICHAEL D | director | 71,915 0.0166% | $2.75 | $198,023 | +30.82% | ||
| 2023-06-02 | Brennan John Owen | director | 25,000 0.006% | $2.83 | $70,700 | +31.77% | ||
| 2023-06-02 | Brennan John Owen | director | 15,000 0.0035% | $2.78 | $41,700 | +31.77% | ||
| 2023-06-01 | Clark Wesley | director | 7,000 0.0016% | $2.91 | $20,370 | +24.15% | ||
| 2021-10-08 | Adcock Richard | CEO & President | 1,930 0.0005% | $8.81 | $16,995 | -38.25% |
| SOON-SHIONG PATRICK | Chairman and CEO | 23750750 2.241% | $196.89M | 2 | 0 | <0.0001% |
| BLASZYK MICHAEL D | director | 71915 0.0068% | $596,175.35 | 1 | 0 | +30.82% |
| Brennan John Owen | director | 15000 0.0014% | $124,350.00 | 2 | 0 | +31.77% |
| Clark Wesley | director | 8000 0.0008% | $66,320.00 | 1 | 0 | +24.15% |
| Wilson Angela | Chief Financial Officer | 3265 0.0003% | $27,066.85 | 1 | 0 | <0.0001% |
| Adcock Richard | CEO & President | 1930 0.0002% | $15,999.70 | 1 | 0 | <0.0001% |
$159,914,414 | 243 | 18.52% | $8.86B | |
$67,892,722 | 138 | 28.28% | $6.25B | |
$273,531,368 | 93 | 38.24% | $9.16B | |
$2,765,836 | 72 | 20.00% | $10.77B | |
$1,801,511 | 23 | 18.58% | $8.41B |
| Increased Positions | 146 | +55.73% | 40M | +28.25% |
| Decreased Positions | 96 | -36.64% | 14M | -10.06% |
| New Positions | 46 | New | 2M | New |
| Sold Out Positions | 29 | Sold Out | 8M | Sold Out |
| Total Postitions | 312 | +19.08% | 169M | +18.18% |
| Vanguard Group Inc | $55,864.00 | 2.81% | 27.66M | +6M | +26.76% | 2025-09-30 |
| Blackrock, Inc. | $40,018.00 | 2.01% | 19.81M | +2M | +11.5% | 2025-09-30 |
| Jane Street Group, Llc | $25,928.00 | 1.3% | 12.84M | +5M | +66.3% | 2025-09-30 |
| State Street Corp | $22,858.00 | 1.15% | 11.32M | +4M | +48.59% | 2025-09-30 |
| Geode Capital Management, Llc | $13,918.00 | 0.7% | 6.89M | +1M | +19.26% | 2025-09-30 |
| Heights Capital Management, Inc | $13,263.00 | 0.67% | 6.57M | +7M | New | 2025-09-30 |
| Woodline Partners Lp | $10,701.00 | 0.54% | 5.3M | +2M | +53.74% | 2025-09-30 |
| Morgan Stanley | $6,815.00 | 0.34% | 3.37M | +401,301 | +13.5% | 2025-09-30 |
| Alphacore Capital Llc | $6,037.00 | 0.3% | 2.99M | +13,666 | +0.46% | 2025-09-30 |
| Susquehanna International Group, Llp | $5,338.00 | 0.27% | 2.64M | +790,746 | +42.7% | 2025-09-30 |